Black Rose Industries Ltd
Black Rose Industries Q4 FY25 earnings call: Revenue & Margins
Q4 FY25 earnings call: what management guided on revenue, margins and order book.
The short version
Standalone sales for FY24-25 have already exceeded FY22 figures in terms of volume. The company has exceeded standalone figures of FY22 in FY24-25, indicating positive volume growth.
From Black Rose Industries Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Standalone sales for FY24-25 have already exceeded FY22 figures in terms of volume.
- Raw material prices have stabilized, aiding better price realization.
- New products like acrylamide solid and N-methylol acrylamide (NMA) are steadily gaining market acceptance.
- Capacity utilization for key products is improving, contributing to better margins and volume growth.
- Export markets, especially in the U.S., may improve once tariff uncertainties clear.
- Company is optimistic about enhancing market share and profitability through new product launches and expanded distribution.
- Ongoing R&D and manufacturing initiatives (e.g., polyacrylamide solid) expected to positively impact growth.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Black Rose Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Polyacrylamide (PAM) solid project is progressing on schedule; commercial production expected by end of the current fiscal or start of next.
- CAPEX for PAM solid estimated between ₹60 to ₹100 crores.
- Additional upcoming projects include an amine manufacturing facility, with a feasibility study underway in collaboration with Koei Chemicals (Japan).
- Total CAPEX for amine and other projects estimated around ₹50 crores.
- Land registration for new parcels is near completion to create a land bank for future projects.
- EC approval for the mines project at Jhagadia site is expected soon.
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Black Rose Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Black Rose Industries Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹104 Cr, net profit ₹9 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Black Rose Industries Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Atul Ltd (Q4 FY25)
Consolidated revenue from operations for 2024-25: ₹5,583 cr, 18% increase YoY from ₹4,726 cr in 2023-24 (Page 36). Key concall takeaways from Atul Ltd's Q4…
- Vidhi Specialty Food Ingredients Ltd (Q4 FY25)
109.5 Crs, up 40.2% YoY (from Rs. Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q4 FY25 earnings call — and how it ranks against sector…
- Chemcon Speciality Chemicals Ltd (Q4 FY25)
54.9 Crs, down 8% YoY from Rs. Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
- Valiant Organics Ltd (Q4 FY25)
Q4-FY25 revenue from operations (consolidated) was INR 2,038 million, a 15.3% year-on-year (YoY) increase from INR 1,768 million in Q4-FY24 (Page 12 and 10)…
Frequently Asked Questions
What were Black Rose Industries Ltd Q4 FY25 results?
Standalone sales for FY24-25 have already exceeded FY22 figures in terms of volume. The company has exceeded standalone figures of FY22 in FY24-25, indicating positive volume growth.
What is Black Rose Industries Ltd share price analysis?
Black Rose Industries Ltd currently shows a neutral. The stock trades at a P/E of 20.5 with a market cap of ₹588 Cr. Investors should review the full earnings analysis for detailed insights.
Is Black Rose Industries Ltd planning capital expenditure?
Polyacrylamide (PAM) solid project is progressing on schedule; commercial production expected by end of the current fiscal or start of next.
Keep Black Rose Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.